Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126365671 | 12636567 | 1 | I | 20160726 | 20160809 | 20160809 | EXP | NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-121396 | RANBAXY | MANNESSE CK, JANSEN PA, VAN MARUM RJ, SIVAL RC, KOK RM, HAFFMANS PM ET AL. CHARACTERISTICS, PREVALENCE, RISK FACTORS, AND UNDERLYING MECHANISM OF HYPONATREMIA IN ELDERLY PATIENTS TREATED WITH ANTIDEPRESSANTS: A CROSS-SECTIONAL STUDY. MATURITAS. 2013;76:357-63 | 0.00 | E | F | Y | 0.00000 | 20160809 | OT | NL | NL |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126365671 | 12636567 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, DAILY | U | 77032 | 20 | MG | |||||||
126365671 | 12636567 | 2 | SS | MIRTAZAPINE. | MIRTAZAPINE | 1 | Unknown | 15 MG, DAILY | U | 0 | 15 | MG | |||||||
126365671 | 12636567 | 3 | SS | Gliclazide | GLICLAZIDE | 1 | Unknown | U | 0 | ||||||||||
126365671 | 12636567 | 4 | SS | Pantoprazol | PANTOPRAZOLE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
126365671 | 12636567 | 5 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | UNK | U | 0 | |||||||||
126365671 | 12636567 | 6 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
126365671 | 12636567 | 7 | SS | OXAZEPAM. | OXAZEPAM | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126365671 | 12636567 | 1 | Product used for unknown indication |
126365671 | 12636567 | 2 | Product used for unknown indication |
126365671 | 12636567 | 3 | Product used for unknown indication |
126365671 | 12636567 | 4 | Product used for unknown indication |
126365671 | 12636567 | 5 | Product used for unknown indication |
126365671 | 12636567 | 6 | Product used for unknown indication |
126365671 | 12636567 | 7 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126365671 | 12636567 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126365671 | 12636567 | Hyponatraemia | |
126365671 | 12636567 | Inappropriate antidiuretic hormone secretion |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |